Immediate Impact

2 by Nobel laureates 26 from Science/Nature 54 standout
Sub-graph 1 of 22

Citing Papers

Interferon- γ and infectious diseases: Lessons and prospects
2024 StandoutScience
Naturally occurring T cell mutations enhance engineered T cell therapies
2024 StandoutNature
9 intermediate papers

Works of JL Stéphan being referenced

Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease
1992
Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease
1992
and 1 more

Author Peers

Author Last Decade Papers Cites
JL Stéphan 749 658 122 309 21 1.3k
O Marie 875 996 142 486 24 1.4k
L Fisher 557 1072 148 234 16 1.7k
CL Verweij 503 400 171 117 26 1.4k
Dawn Jones 726 734 146 96 28 1.4k
Sonnie Kim 385 387 197 290 24 1.4k
Richard Childs 625 637 196 149 18 1.4k
Stephen J. Rosenfeld 356 818 149 412 27 1.5k
Kathrin Rieger 437 509 281 209 30 1.3k
Richard Champlin 348 860 196 254 32 1.4k
Marco Marziali 582 356 219 244 48 1.5k

All Works

Loading papers...

Rankless by CCL
2026